These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25128192)
1. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells. Ukaji T; Umezawa K Adv Biol Regul; 2014 Sep; 56():108-15. PubMed ID: 25128192 [TBL] [Abstract][Full Text] [Related]
2. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200 [TBL] [Abstract][Full Text] [Related]
3. NF-κB and the link between inflammation and cancer. DiDonato JA; Mercurio F; Karin M Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells. Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701 [TBL] [Abstract][Full Text] [Related]
5. NF-κB signaling in cancer stem cells: a promising therapeutic target? Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853 [TBL] [Abstract][Full Text] [Related]
6. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo. Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211 [TBL] [Abstract][Full Text] [Related]
7. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways. Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836 [TBL] [Abstract][Full Text] [Related]
8. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity. He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071 [TBL] [Abstract][Full Text] [Related]
9. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates. de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554 [TBL] [Abstract][Full Text] [Related]
10. Using NF-κB as a molecular target for theranostics in radiation oncology research. Liu YC; Chiang IT; Hsu FT; Hwang JJ Expert Rev Mol Diagn; 2012 Mar; 12(2):139-46. PubMed ID: 22369374 [TBL] [Abstract][Full Text] [Related]
11. Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ. Umezawa K Biomed Pharmacother; 2011 Jul; 65(4):252-9. PubMed ID: 21723080 [TBL] [Abstract][Full Text] [Related]
12. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482 [TBL] [Abstract][Full Text] [Related]
13. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392 [TBL] [Abstract][Full Text] [Related]
14. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. St-Germain ME; Gagnon V; Parent S; Asselin E Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316 [TBL] [Abstract][Full Text] [Related]
15. Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent. Katsman A; Umezawa K; Bonavida B Drug Resist Updat; 2007; 10(1-2):1-12. PubMed ID: 17306602 [TBL] [Abstract][Full Text] [Related]
16. Regulation of apoptosis pathways in cancer stem cells. Fulda S Cancer Lett; 2013 Sep; 338(1):168-73. PubMed ID: 22429999 [TBL] [Abstract][Full Text] [Related]
17. Wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human breast cancer by possible involvement of the NF-κB pathways. Fuke Y; Hishinuma M; Namikawa M; Oishi Y; Matsuzaki T Nutr Cancer; 2014; 66(5):879-87. PubMed ID: 24895898 [TBL] [Abstract][Full Text] [Related]
19. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742 [TBL] [Abstract][Full Text] [Related]
20. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells. Kim HR; Park CG; Jung JY Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]